Pfizer records over 22$billion revenue in Q3 from Covid products
The New York-based drug company on Tuesday said it now expects to end the year with revenue in the range of $99.5 billion to $102 billion
Russia doubles profit from energy during war
Soaring prices have more than compensated Russia for the loss in sales volume due to sanctions
Pfizer Revenue Boosted by Covid-19 Drugs (infographic)
Pfizer reported its fourth-quarter and full-year results on Tuesday